English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [2350]
News [4892]
Articles [202]
Editorials [8]
Conferences [136]
elearning [14]
A new targeted treatment shows promise for select patients with stomach cancer
A new targeted treatment shows promise for select patients with stomach cancer
A calculator to predict benefit from adjuvant transarterial chemoembolisation for hepatocellular carcinoma
A calculator to predict benefit from adjuvant transarterial chemoembolisation for hepatocellular carcinoma
Vitamin D supplementation was found to improve more than 1.5 fold survival of cancers of the digestive tract in patients with a cancer fighting immune system
Vitamin D supplementation was found to improve more than 1.5 fold survival of cancers of the digestive tract in...
Oestrogen-negative cancers respond to anti-oestrogenic therapies
Oestrogen-negative cancers respond to anti-oestrogenic therapies
Journal review summarises latest research on gamma delta T cells for tumour immunotherapy
Journal review summarises latest research on gamma delta T cells for tumour immunotherapy
Researchers discover potential target for gastric cancers associated with Epstein-Barr virus
Researchers discover potential target for gastric cancers associated with Epstein-Barr virus
Cancel cervical cancer – In conversation with Brazil, Colombia, and Uruguay experts
Cancel cervical cancer – In conversation with Brazil, Colombia, and Uruguay experts
Oestrogen receptor mutation study suggests potential treatments for endometrial cancers
Oestrogen receptor mutation study suggests potential treatments for endometrial cancers
Additional COVID-19 boosters can benefit cancer patients—how often they should get them depends on their treatment
Additional COVID-19 boosters can benefit cancer patients—how often they should get them depends on their treatment
Aggressive luminal breast cancer: Are cis-spliced fusion proteins pathological?
Aggressive luminal breast cancer: Are cis-spliced fusion proteins pathological?
<1...7071727374...490>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top